chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Dizziness, Headache, Myalgia
Clinical narrative: Dizziness; Back Ache; Joint Pain; Muscle Pain; Headache; This spontaneous case was reported by a nurse and describes the occurrence of DIZZINESS (Dizziness), BACK PAIN (Back Ache), ARTHRALGIA (Joint Pain), MYALGIA (Muscle Pain) and HEADACHE (Headache) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L29) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced DIZZINESS (Dizziness), BACK PAIN (Back Ache), ARTHRALGIA (Joint Pain), MYALGIA (Muscle Pain) and HEADACHE (Headache). In February 2021, DIZZINESS (Dizziness), BACK PAIN (Back Ache), ARTHRALGIA (Joint Pain), MYALGIA (Muscle Pain) and HEADACHE (Headache) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was reported.  No treatment information was reported for the events. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Atrial flutter, Dyspnoea, Headache
Clinical narrative: fluttered or rushed heart beats; having a bad headache; difficulty breathing; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (difficulty breathing), ATRIAL FLUTTER (fluttered or rushed heart beats) and HEADACHE (having a bad headache) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced DYSPNOEA (difficulty breathing). On 21-Mar-2021, the patient experienced ATRIAL FLUTTER (fluttered or rushed heart beats) and HEADACHE (having a bad headache). On 19-Mar-2021, DYSPNOEA (difficulty breathing) had resolved. At the time of the report, ATRIAL FLUTTER (fluttered or rushed heart beats) had not resolved and HEADACHE (having a bad headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No laboratory details were  provided.  Treatment details included pain medication and sinus pills.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Vaccination site erythema
Clinical narrative: red area on my arm; extreme nausea; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (extreme nausea) and VACCINATION SITE ERYTHEMA (red area on my arm) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     The patient's past medical history included Headache and Weakness.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Mar-2021, the patient experienced NAUSEA (extreme nausea). On 19-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (red area on my arm). At the time of the report, NAUSEA (extreme nausea) and VACCINATION SITE ERYTHEMA (red area on my arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment details included ondansetron.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Hives; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Hives) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 012M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced URTICARIA (Hives). At the time of the report, URTICARIA (Hives) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not applicable. No concomitant medications information was reported. No treatment medications were provided.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Fatigue, Rash morbilliform
Clinical narrative: rash all over like measles; Skin was red like she had measles; Tired; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH MORBILLIFORM (rash all over like measles), ERYTHEMA (Skin was red like she had measles) and FATIGUE (Tired) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003A21A and 010M20A) for COVID-19 vaccination.     Concurrent medical conditions included Cholesterol since 2010. Concomitant products included ATORVASTATIN for Cholesterol.   On 17-Feb-2021 at 2:15 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021 at 2:15 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Mar-2021, the patient experienced RASH MORBILLIFORM (rash all over like measles), ERYTHEMA (Skin was red like she had measles) and FATIGUE (Tired). On 22-Mar-2021, RASH MORBILLIFORM (rash all over like measles) and ERYTHEMA (Skin was red like she had measles) had resolved. At the time of the report, FATIGUE (Tired) had resolved.            No treatment medication was taken.   Most recent FOLLOW-UP information incorporated above includes: On 06-Apr-2021: NNI On 08-Apr-2021: Vaccination time added, event outcome updated (resolved),  medical history and indication for concomitant medication updated.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Rash, Rash pruritic, Swelling, Urticaria
Clinical narrative: hives all over the body; pretty heavy rash; itching (rash); rash hot to touch; rash swollen; severe diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives all over the body), DIARRHOEA (severe diarrhea), RASH (pretty heavy rash), RASH PRURITIC (itching (rash)) and VACCINATION SITE WARMTH (rash hot to touch) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced DIARRHOEA (severe diarrhea). On 12-Mar-2021, the patient experienced RASH (pretty heavy rash), RASH PRURITIC (itching (rash)), VACCINATION SITE WARMTH (rash hot to touch) and SWELLING (rash swollen). On 17-Mar-2021, the patient experienced URTICARIA (hives all over the body). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Itching, at an unspecified dose and frequency. On 17-Mar-2021, RASH (pretty heavy rash), RASH PRURITIC (itching (rash)), VACCINATION SITE WARMTH (rash hot to touch) and SWELLING (rash swollen) had resolved. At the time of the report, URTICARIA (hives all over the body) had not resolved and DIARRHOEA (severe diarrhea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: hives all over the body; pretty heavy rash; itching (rash); rash hot to touch; rash swollen; severe diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives all over the body), DIARRHOEA (severe diarrhea), RASH (pretty heavy rash), RASH PRURITIC (itching (rash)) and VACCINATION SITE WARMTH (rash hot to touch) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced DIARRHOEA (severe diarrhea). On 12-Mar-2021, the patient experienced RASH (pretty heavy rash), RASH PRURITIC (itching (rash)), VACCINATION SITE WARMTH (rash hot to touch) and SWELLING (rash swollen). On 17-Mar-2021, the patient experienced URTICARIA (hives all over the body). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Itching, at an unspecified dose and frequency. On 17-Mar-2021, RASH (pretty heavy rash), RASH PRURITIC (itching (rash)), VACCINATION SITE WARMTH (rash hot to touch) and SWELLING (rash swollen) had resolved. At the time of the report, URTICARIA (hives all over the body) had not resolved and DIARRHOEA (severe diarrhea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: a little sore on the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (a little sore on the injection site) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced VACCINATION SITE PAIN (a little sore on the injection site). At the time of the report, VACCINATION SITE PAIN (a little sore on the injection site) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant medications were not reported.  No Treatment medication was reported.   This case was linked to MOD-2021-052533 (Patient Link).
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0108214) for COVID-19 vaccination.     The patient's past medical history included Vertigo. Concomitant products included VENLAFAXINE, SIMVASTATIN and OMEPRAZOLE for an unknown indication.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Mar-2021, the patient experienced COVID-19 (COVID-19). At the time of the report, COVID-19 (COVID-19) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medications included.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pyrexia
Clinical narrative: Fatigue; Low Grade Fever; This spontaneous case was reported by a physician and describes the occurrence of FATIGUE (Fatigue) and PYREXIA (Low Grade Fever) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced FATIGUE (Fatigue) and PYREXIA (Low Grade Fever). In February 2021, FATIGUE (Fatigue) and PYREXIA (Low Grade Fever) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were reported.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Myalgia, Nausea, Vomiting
Clinical narrative: Chills; Body Aches; Nausea; Vomiting; This spontaneous case was reported by a nurse and describes the occurrence of CHILLS (Chills), MYALGIA (Body Aches), NAUSEA (Nausea) and VOMITING (Vomiting) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced CHILLS (Chills), MYALGIA (Body Aches), NAUSEA (Nausea) and VOMITING (Vomiting). In February 2021, CHILLS (Chills), MYALGIA (Body Aches), NAUSEA (Nausea) and VOMITING (Vomiting) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the events was Not Applicable. No concomitant information was reported.  No treatment information was reported.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pain, Somnolence
Clinical narrative: slept a lot; soreness is like size of Orange; fatigue; chills; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (slept a lot), PAIN (soreness is like size of Orange), FATIGUE (fatigue) and CHILLS (chills) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced PAIN (soreness is like size of Orange), FATIGUE (fatigue) and CHILLS (chills). On 12-Mar-2021, the patient experienced SOMNOLENCE (slept a lot). The patient was treated with IBUPROFEN at an unspecified dose and frequency and ACETAMINOPHEN at an unspecified dose and frequency. At the time of the report, SOMNOLENCE (slept a lot), PAIN (soreness is like size of Orange), FATIGUE (fatigue) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  On, 15-Mar-2021 her orange size injection site had shrieked as she used ice pack..
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Erythema, Fatigue, Headache, Myalgia
Clinical narrative: soreness on muscle in between the armpit and chest; soreness; redness; fever; Chills; headache; tiredness; arm sore; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (tiredness), PAIN IN EXTREMITY (arm sore), PYREXIA (fever), CHILLS (Chills) and HEADACHE (headache) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Cholesterol.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced FATIGUE (tiredness) and PAIN IN EXTREMITY (arm sore). On 17-Mar-2021, the patient experienced PYREXIA (fever), CHILLS (Chills) and HEADACHE (headache). On 18-Mar-2021, the patient experienced PAIN (soreness) and ERYTHEMA (redness). On 19-Mar-2021, the patient experienced MYALGIA (soreness on muscle in between the armpit and chest). At the time of the report, FATIGUE (tiredness), PAIN IN EXTREMITY (arm sore), PYREXIA (fever), CHILLS (Chills), HEADACHE (headache), PAIN (soreness), ERYTHEMA (redness) and MYALGIA (soreness on muscle in between the armpit and chest) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant products included cholesterol medicine.
Age: 45.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, Pyrexia
Clinical narrative: soreness on muscle in between the armpit and chest; soreness; redness; fever; Chills; headache; tiredness; arm sore; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (tiredness), PAIN IN EXTREMITY (arm sore), PYREXIA (fever), CHILLS (Chills) and HEADACHE (headache) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Cholesterol.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced FATIGUE (tiredness) and PAIN IN EXTREMITY (arm sore). On 17-Mar-2021, the patient experienced PYREXIA (fever), CHILLS (Chills) and HEADACHE (headache). On 18-Mar-2021, the patient experienced PAIN (soreness) and ERYTHEMA (redness). On 19-Mar-2021, the patient experienced MYALGIA (soreness on muscle in between the armpit and chest). At the time of the report, FATIGUE (tiredness), PAIN IN EXTREMITY (arm sore), PYREXIA (fever), CHILLS (Chills), HEADACHE (headache), PAIN (soreness), ERYTHEMA (redness) and MYALGIA (soreness on muscle in between the armpit and chest) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant products included cholesterol medicine.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Heart rate increased, Nausea, Vomiting
Clinical narrative: heart rate 140s 150; chills; nausea; threw up; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (heart rate 140s 150), CHILLS (chills), NAUSEA (nausea) and VOMITING (threw up) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     Concomitant products included COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) for an unknown indication.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced HEART RATE INCREASED (heart rate 140s 150), CHILLS (chills), NAUSEA (nausea) and VOMITING (threw up). At the time of the report, HEART RATE INCREASED (heart rate 140s 150), CHILLS (chills), NAUSEA (nausea) and VOMITING (threw up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Chest pain, Chills, Fatigue, Flushing
Clinical narrative: Rash; Felt tired; Chills; Nausea; Fever; swelling of axillary lymphnodes; Flushing in the face; High blood pressure; Increase pulse; Chest pain; Sweats; Chest discomfort; arm pain; This spontaneous case was reported by a consumer and describes the occurrence of FLUSHING (Flushing in the face), HYPERTENSION (High blood pressure), HEART RATE INCREASED (Increase pulse), CHEST PAIN (Chest pain) and HYPERHIDROSIS (Sweats) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included High cholesterol in 2007 and Acid reflux (esophageal) in 2018. Concurrent medical conditions included Hypertension since 2007 and Sulfonamide allergy. Concomitant products included LISINOPRIL and AMLODIPINE for Blood pressure high, ATORVASTATINE [ATORVASTATIN] for Cholesterol, OMEPRAZOLE for Reflux gastritis.   On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm pain). On 16-Feb-2021, the patient experienced FLUSHING (Flushing in the face), HYPERTENSION (High blood pressure), HEART RATE INCREASED (Increase pulse), CHEST PAIN (Chest pain), HYPERHIDROSIS (Sweats), CHEST DISCOMFORT (Chest discomfort), FATIGUE (Felt tired), CHILLS (Chills), NAUSEA (Nausea), PYREXIA (Fever) and LYMPHADENOPATHY (swelling of axillary lymphnodes). On an unknown date, the patient experienced RASH (Rash). At the time of the report, FLUSHING (Flushing in the face), HYPERHIDROSIS (Sweats), NAUSEA (Nausea) and PYREXIA (Fever) outcome was unknown and HYPERTENSION (High blood pressure), HEART RATE INCREASED (Increase pulse), CHEST PAIN (Chest pain), PAIN IN EXTREMITY (arm pain), CHEST DISCOMFORT (Chest discomfort), RASH (Rash), FATIGUE (Felt tired), CHILLS (Chills) and LYMPHADENOPATHY (swelling of axillary lymphnodes) had resolved.            Treatment medication included Benadryl and Tylenol.  Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-015889 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 17-May-2021: Reporter details, patient details, concomitant medications and outcome was updated
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased, Hyperhidrosis, Hypertension, Lymphadenopathy, Nausea
Clinical narrative: Rash; Felt tired; Chills; Nausea; Fever; swelling of axillary lymphnodes; Flushing in the face; High blood pressure; Increase pulse; Chest pain; Sweats; Chest discomfort; arm pain; This spontaneous case was reported by a consumer and describes the occurrence of FLUSHING (Flushing in the face), HYPERTENSION (High blood pressure), HEART RATE INCREASED (Increase pulse), CHEST PAIN (Chest pain) and HYPERHIDROSIS (Sweats) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included High cholesterol in 2007 and Acid reflux (esophageal) in 2018. Concurrent medical conditions included Hypertension since 2007 and Sulfonamide allergy. Concomitant products included LISINOPRIL and AMLODIPINE for Blood pressure high, ATORVASTATINE [ATORVASTATIN] for Cholesterol, OMEPRAZOLE for Reflux gastritis.   On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm pain). On 16-Feb-2021, the patient experienced FLUSHING (Flushing in the face), HYPERTENSION (High blood pressure), HEART RATE INCREASED (Increase pulse), CHEST PAIN (Chest pain), HYPERHIDROSIS (Sweats), CHEST DISCOMFORT (Chest discomfort), FATIGUE (Felt tired), CHILLS (Chills), NAUSEA (Nausea), PYREXIA (Fever) and LYMPHADENOPATHY (swelling of axillary lymphnodes). On an unknown date, the patient experienced RASH (Rash). At the time of the report, FLUSHING (Flushing in the face), HYPERHIDROSIS (Sweats), NAUSEA (Nausea) and PYREXIA (Fever) outcome was unknown and HYPERTENSION (High blood pressure), HEART RATE INCREASED (Increase pulse), CHEST PAIN (Chest pain), PAIN IN EXTREMITY (arm pain), CHEST DISCOMFORT (Chest discomfort), RASH (Rash), FATIGUE (Felt tired), CHILLS (Chills) and LYMPHADENOPATHY (swelling of axillary lymphnodes) had resolved.            Treatment medication included Benadryl and Tylenol.  Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-015889 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 17-May-2021: Reporter details, patient details, concomitant medications and outcome was updated
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia, Rash
Clinical narrative: Rash; Felt tired; Chills; Nausea; Fever; swelling of axillary lymphnodes; Flushing in the face; High blood pressure; Increase pulse; Chest pain; Sweats; Chest discomfort; arm pain; This spontaneous case was reported by a consumer and describes the occurrence of FLUSHING (Flushing in the face), HYPERTENSION (High blood pressure), HEART RATE INCREASED (Increase pulse), CHEST PAIN (Chest pain) and HYPERHIDROSIS (Sweats) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included High cholesterol in 2007 and Acid reflux (esophageal) in 2018. Concurrent medical conditions included Hypertension since 2007 and Sulfonamide allergy. Concomitant products included LISINOPRIL and AMLODIPINE for Blood pressure high, ATORVASTATINE [ATORVASTATIN] for Cholesterol, OMEPRAZOLE for Reflux gastritis.   On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm pain). On 16-Feb-2021, the patient experienced FLUSHING (Flushing in the face), HYPERTENSION (High blood pressure), HEART RATE INCREASED (Increase pulse), CHEST PAIN (Chest pain), HYPERHIDROSIS (Sweats), CHEST DISCOMFORT (Chest discomfort), FATIGUE (Felt tired), CHILLS (Chills), NAUSEA (Nausea), PYREXIA (Fever) and LYMPHADENOPATHY (swelling of axillary lymphnodes). On an unknown date, the patient experienced RASH (Rash). At the time of the report, FLUSHING (Flushing in the face), HYPERHIDROSIS (Sweats), NAUSEA (Nausea) and PYREXIA (Fever) outcome was unknown and HYPERTENSION (High blood pressure), HEART RATE INCREASED (Increase pulse), CHEST PAIN (Chest pain), PAIN IN EXTREMITY (arm pain), CHEST DISCOMFORT (Chest discomfort), RASH (Rash), FATIGUE (Felt tired), CHILLS (Chills) and LYMPHADENOPATHY (swelling of axillary lymphnodes) had resolved.            Treatment medication included Benadryl and Tylenol.  Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-015889 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 17-May-2021: Reporter details, patient details, concomitant medications and outcome was updated
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling hot, Pyrexia, Rash, Rash pruritic
Clinical narrative: rash is very itchy; warm to touch its going all way down to elbow; fever; little chills; rash; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (rash is very itchy), FEELING HOT (warm to touch its going all way down to elbow), RASH (rash), PYREXIA (fever) and CHILLS (little chills) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced RASH (rash). On 08-Mar-2021, the patient experienced PYREXIA (fever) and CHILLS (little chills). On 15-Mar-2021, the patient experienced RASH PRURITIC (rash is very itchy) and FEELING HOT (warm to touch its going all way down to elbow). At the time of the report, RASH PRURITIC (rash is very itchy) and RASH (rash) had not resolved and FEELING HOT (warm to touch its going all way down to elbow), PYREXIA (fever) and CHILLS (little chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported by investigator No treatment medications provided by the reporter.   No treatment medications were reported.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Body temperature, Dysphonia, Parosmia
Clinical narrative: woke up in the middle of night; bad sinus infection, but she doesn't feel sick nor is her nose plugged; smell a burning smell, like if food was burning.; voice seems different; cannot smell; cannot taste anything from vinegar, salty and sweets.; her eyes are itchy, but she states that she has allergies; 101.6 degrees Fahrenheit; This spontaneous case was reported by a consumer and describes the occurrence of SLEEP DISORDER (woke up in the middle of night), SINUSITIS (bad sinus infection, but she doesn't feel sick nor is her nose plugged), PAROSMIA (smell a burning smell, like if food was burning.), DYSPHONIA (voice seems different) and ANOSMIA (cannot smell) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031A21A and 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced SLEEP DISORDER (woke up in the middle of night), SINUSITIS (bad sinus infection, but she doesn't feel sick nor is her nose plugged), PAROSMIA (smell a burning smell, like if food was burning.), DYSPHONIA (voice seems different), ANOSMIA (cannot smell), AGEUSIA (cannot taste anything from vinegar, salty and sweets.), PRURITUS (her eyes are itchy, but she states that she has allergies) and PYREXIA (101.6 degrees Fahrenheit). At the time of the report, SLEEP DISORDER (woke up in the middle of night), SINUSITIS (bad sinus infection, but she doesn't feel sick nor is her nose plugged), PAROSMIA (smell a burning smell, like if food was burning.), DYSPHONIA (voice seems different), PRURITUS (her eyes are itchy, but she states that she has allergies) and PYREXIA (101.6 degrees Fahrenheit) outcome was unknown and ANOSMIA (cannot smell) and AGEUSIA (cannot taste anything from vinegar, salty and sweets.) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 (High) High.         Treatment medication included acetaminophen for fever.   Concomitant product use was not reported.   This case was linked to MOD-2021-052484 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 08-May-2021: Updated email address of the patient. Updated the event outcome for cannot smell and cannot taste from unknown to not recovered.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Pyrexia, Sinusitis, Sleep disorder
Clinical narrative: woke up in the middle of night; bad sinus infection, but she doesn't feel sick nor is her nose plugged; smell a burning smell, like if food was burning.; voice seems different; cannot smell; cannot taste anything from vinegar, salty and sweets.; her eyes are itchy, but she states that she has allergies; 101.6 degrees Fahrenheit; This spontaneous case was reported by a consumer and describes the occurrence of SLEEP DISORDER (woke up in the middle of night), SINUSITIS (bad sinus infection, but she doesn't feel sick nor is her nose plugged), PAROSMIA (smell a burning smell, like if food was burning.), DYSPHONIA (voice seems different) and ANOSMIA (cannot smell) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031A21A and 031L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced SLEEP DISORDER (woke up in the middle of night), SINUSITIS (bad sinus infection, but she doesn't feel sick nor is her nose plugged), PAROSMIA (smell a burning smell, like if food was burning.), DYSPHONIA (voice seems different), ANOSMIA (cannot smell), AGEUSIA (cannot taste anything from vinegar, salty and sweets.), PRURITUS (her eyes are itchy, but she states that she has allergies) and PYREXIA (101.6 degrees Fahrenheit). At the time of the report, SLEEP DISORDER (woke up in the middle of night), SINUSITIS (bad sinus infection, but she doesn't feel sick nor is her nose plugged), PAROSMIA (smell a burning smell, like if food was burning.), DYSPHONIA (voice seems different), PRURITUS (her eyes are itchy, but she states that she has allergies) and PYREXIA (101.6 degrees Fahrenheit) outcome was unknown and ANOSMIA (cannot smell) and AGEUSIA (cannot taste anything from vinegar, salty and sweets.) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101 (High) High.         Treatment medication included acetaminophen for fever.   Concomitant product use was not reported.   This case was linked to MOD-2021-052484 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 08-May-2021: Updated email address of the patient. Updated the event outcome for cannot smell and cannot taste from unknown to not recovered.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Bedridden, Decreased appetite, Fatigue, Feeling abnormal, Lethargy
Clinical narrative: fatigue; couldn't get out of bed for about a week; brain fog that felt like she had dementia; lethargic; brain fog; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of FEELING ABNORMAL (brain fog), FATIGUE (fatigue), BEDRIDDEN (couldn't get out of bed for about a week), DECREASED APPETITE (brain fog that felt like she had dementia) and LETHARGY (lethargic) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     The patient's past medical history included Lyme disease since an unknown date. Concomitant products included MULTI VITAMIN & MINERAL and ASCORBIC ACID (VITAMIN C ACID) for an unknown indication, FISH OIL.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced FEELING ABNORMAL (brain fog), BEDRIDDEN (couldn't get out of bed for about a week), DECREASED APPETITE (brain fog that felt like she had dementia) and LETHARGY (lethargic). On an unknown date, the patient experienced FATIGUE (fatigue). At the time of the report, FEELING ABNORMAL (brain fog), BEDRIDDEN (couldn't get out of bed for about a week), DECREASED APPETITE (brain fog that felt like she had dementia) and LETHARGY (lethargic) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient is treated with vitamin D and B12.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Lip swelling, Urticaria
Clinical narrative: allergic reaction; swollen lips with hives within 4 hours; swollen lips with hives within 4 hours; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (allergic reaction), LIP SWELLING (swollen lips with hives within 4 hours) and URTICARIA (swollen lips with hives within 4 hours) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 014M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced HYPERSENSITIVITY (allergic reaction), LIP SWELLING (swollen lips with hives within 4 hours) and URTICARIA (swollen lips with hives within 4 hours). At the time of the report, HYPERSENSITIVITY (allergic reaction), LIP SWELLING (swollen lips with hives within 4 hours) and URTICARIA (swollen lips with hives within 4 hours) had resolved.            No concomitant medications were reported.  No laboratory details were  provided.  No treatment medications were reported.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: Injection site warm; Injection site itch; Delayed 3" pink circle at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Injection site warm), VACCINATION SITE PRURITUS (Injection site itch) and VACCINATION SITE ERYTHEMA (Delayed 3" pink circle at injection site) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Injection site warm), VACCINATION SITE PRURITUS (Injection site itch) and VACCINATION SITE ERYTHEMA (Delayed 3" pink circle at injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) (topical) at an unspecified dose and frequency. On 12-Mar-2021, VACCINATION SITE PRURITUS (Injection site itch) had resolved. At the time of the report, VACCINATION SITE WARMTH (Injection site warm) and VACCINATION SITE ERYTHEMA (Delayed 3" pink circle at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications information was reported.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Dyspnoea, Feeling abnormal, Headache, Heart rate increased
Clinical narrative: rapid heart rate; shortness of breath that wasn't sever; hurts to sit; very sore; like someone crashed in her right side; headache; severe discomfort; A spontaneous report was received from a consumer concerning a 65-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events rapid heart rate, shortness of breath that wasn't sever, hurts to sit, very sore, like someone crashed in her right side, headache, severe discomfort.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 17 Mar 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 045A21A) intramuscularly in the right arm for prophylaxis of COVID-19 infection.  On 17 Mar 2021, the patient experienced the event(s) rapid heart rate, shortness of breath that wasn't sever, hurts to sit, very sore, like someone crashed in her right side, headache, severe discomfort.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.  On 18 Mar 2021 the outcome of event(s), rapid heart rate, shortness of breath that wasn't sever was resolved. On19 Mar 2021 the outcome of event(s), hurts to sit, very sore, like someone crashed in her right side, headache, severe discomfort was resolved.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Sitting disability
Clinical narrative: rapid heart rate; shortness of breath that wasn't sever; hurts to sit; very sore; like someone crashed in her right side; headache; severe discomfort; A spontaneous report was received from a consumer concerning a 65-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events rapid heart rate, shortness of breath that wasn't sever, hurts to sit, very sore, like someone crashed in her right side, headache, severe discomfort.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 17 Mar 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 045A21A) intramuscularly in the right arm for prophylaxis of COVID-19 infection.  On 17 Mar 2021, the patient experienced the event(s) rapid heart rate, shortness of breath that wasn't sever, hurts to sit, very sore, like someone crashed in her right side, headache, severe discomfort.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.  On 18 Mar 2021 the outcome of event(s), rapid heart rate, shortness of breath that wasn't sever was resolved. On19 Mar 2021 the outcome of event(s), hurts to sit, very sore, like someone crashed in her right side, headache, severe discomfort was resolved.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Malaise, Pain
Clinical narrative: Feels sick similiar to when she had Covid; Body Aches; Headaches; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Feels sick similiar to when she had Covid), PAIN (Body Aches) and HEADACHE (Headaches) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045A21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (January).    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced MALAISE (Feels sick similiar to when she had Covid), PAIN (Body Aches) and HEADACHE (Headaches). The patient was treated with ACETYLSALICYLIC ACID (ASPIRIN 81) for Headache and Pain, at a dose of 1 dosage form. At the time of the report, MALAISE (Feels sick similiar to when she had Covid), PAIN (Body Aches) and HEADACHE (Headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided
Sex: U
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: giving 1st dose to a 17 and 1/2 year old patient; A spontaneous report was received from a health care professional, concerning an unidentified patient of 17 and 1/2 years old, who received Moderna's COVID-19 vaccine and experienced no symptoms.    The patient's medical history was not provided. Concomitant product use was not provided by the reporter.  On an unspecified date, prior to the onset of events, the patient received their first of two planned doses of mRNA-1273 via unknown route for COVID-19 infection prophylaxis.  The patient experienced no symptoms.  Action taken with mRNA-1273 in response to the event was not reported.  The outcome of the event giving 1st dose to a 17 and 1/2 year old patient/Product administered to patient of inappropriate age was considered as resolved on an unknown date..; Sender's Comments: This report refers to a case of product administered to patient of inappropriate age (17 1/2 year old) for mRNA-1273 (lot number unknown) with no associated AEs reported.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Meniscus injury, Mobility decreased, Pyrexia, Vaccination site rash
Clinical narrative: cannot move; terrible torn meniscus; fever of 100.8F; rash under the injection site; This spontaneous case was reported by a consumer and describes the occurrence of MOBILITY DECREASED (cannot move), MENISCUS INJURY (terrible torn meniscus), PYREXIA (fever of 100.8F) and VACCINATION SITE RASH (rash under the injection site) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis and Lupus-like syndrome. Concomitant products included HYDROXYCHLOROQUINE for Lupus-like syndrome.    On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MOBILITY DECREASED (cannot move), MENISCUS INJURY (terrible torn meniscus), PYREXIA (fever of 100.8F) and VACCINATION SITE RASH (rash under the injection site). At the time of the report, MOBILITY DECREASED (cannot move), MENISCUS INJURY (terrible torn meniscus), PYREXIA (fever of 100.8F) and VACCINATION SITE RASH (rash under the injection site) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 100.8 (High) 100.8 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment details was provided.
Sex: U
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: patient who is currently detained and broke out in a rash all over; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of RASH (patient who is currently detained and broke out in a rash all over) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (patient who is currently detained and broke out in a rash all over). At the time of the report, RASH (patient who is currently detained and broke out in a rash all over) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were received. No treatment medications were received.
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Pyrexia
Clinical narrative: not feeling well; Patient has a little bit of a fever; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (not feeling well) and PYREXIA (Patient has a little bit of a fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced PYREXIA (Patient has a little bit of a fever). On an unknown date, the patient experienced FEELING ABNORMAL (not feeling well). At the time of the report, FEELING ABNORMAL (not feeling well) and PYREXIA (Patient has a little bit of a fever) outcome was unknown.            No concomitant medication were provided.  Treatment medication was not provided